June 17, 2026

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN protein loss is associated...

recent articles

A couple of weeks have passed and enough time has passed to digest what I thought about the CAP Companion Society I was fortunate enough to speak at the recent USCAP meeting.  Unfortunately, this was the only part of the meeting I was...

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in...

I recently had a chance to look at Methods in Medical Informatics, the latest of several books by Jules Berman, PhD, MD, published last year.  Three computer languages satisfy the minimum requirements for biomedical programming:...

Risk of Misdiagnosis Due to Tissue Contamination May be Higher for Certain Specimen Types:Changes to Laboratory Staining Techniques Offer Opportunity to Reduce Contamination Events FREE Special Edition White Paper Download Your FREE Special...

BOSTON – A new platform created specifically to boost healthcare IT innovation is now available to the public, kicking off a $5,000 competition that challenges developers to create Web applications for patients, physicians and public...

Leica, with its SCN400 scanner from the latest of the traditional microscope manufacturers continues to move systems and have early success.  Add to that the fact that digital pathology continues to expand in...

OR

platinum partners

gold partners

Silver Partners

Media Partners